Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
Author(s) -
Shanshan He,
Billy Lin,
Virginia Chu,
Zongyi Hu,
Xin Hu,
Jingbo Xiao,
Amy Q. Wang,
Cameron J. Schweitzer,
Qisheng Li,
Michio Imamura,
Nobuhiko Hiraga,
Noel Southall,
Marc Ferrer,
Wei Zheng,
Kazuaki Chayama,
Juan Marugán,
T. Jake Liang
Publication year - 2015
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.3010286
Subject(s) - medicine , sofosbuvir , hepatitis c virus , enfuvirtide , ribavirin , boceprevir , hepatocellular carcinoma , drug repositioning , pharmacology , antihistamine , telaprevir , hepatitis c , drug , combination therapy , virology , virus , immunology , antigen , gp41 , epitope
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom